{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Supplementary Table 4"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Supplementary Table 4","index":0,"n_rows":35,"n_cols":5,"rows_kept":35,"merged":[[34,0,34,4]],"flags":["formulas_cached_only"]}
["GO BP TERM","GENES","BETA","SE","P-VALUE"]
["ATRIOVENTRICULAR CANAL DEVELOPMENT",13,0.68949,0.21185,0.00056875]
["REGULATION OF GLUCONEOGENESIS",48,0.33606,0.10405,0.00062041]
["REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION",50,0.32063,0.1028,0.00090875]
["UREA METABOLIC PROCESS",11,0.55236,0.18287,0.0012633]
["UREA CYCLE",10,0.55697,0.19851,0.0025126]
["PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME",18,0.42086,0.15309,0.0029901]
["NEGATIVE REGULATION OF GLUCONEOGENESIS",16,0.51104,0.1875,0.0032116]
["T HELPER 17 CELL LINEAGE COMMITMENT",13,0.64055,0.23644,0.0033749]
["POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE",121,0.1853,0.069848,0.0039937]
["REGULATION OF ALPHA BETA T CELL DIFFERENTIATION",67,0.24018,0.091551,0.0043557]
["NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY",35,0.3124,0.1194,0.0044463]
["RIBONUCLEOPROTEIN COMPLEX BIOGENESIS",418,0.084644,0.032467,0.0045686]
["SNRNA PROCESSING",24,0.33659,0.12934,0.0046331]
["SNRNA 3 END PROCESSING",20,0.36303,0.13957,0.004651]
["CARDIAC PACEMAKER CELL DIFFERENTIATION",10,0.5936,0.22884,0.0047467]
["REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT",11,0.59514,0.23126,0.0050366]
["ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT",21,0.45558,0.17735,0.0051041]
["REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS",95,0.19053,0.075096,0.0055911]
["POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION",29,0.34421,0.13613,0.0057288]
["REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS",34,0.28894,0.11445,0.0057944]
["REGULATION OF VASCULOGENESIS",16,0.44563,0.17758,0.0060487]
["CARDIAC ATRIUM MORPHOGENESIS",29,0.36827,0.14684,0.0060758]
["REGULATION OF METAPHASE PLATE CONGRESSION",11,0.4808,0.19381,0.0065588]
["DENDRITE SELF AVOIDANCE",14,0.52735,0.21522,0.0071402]
["PROTEIN K11 LINKED DEUBIQUITINATION",10,0.56962,0.23498,0.0076764]
["NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE",14,0.40418,0.16746,0.007901]
["RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM",47,0.21635,0.089674,0.0079236]
["NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING",16,0.42684,0.17822,0.0083135]
["ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION",12,0.43248,0.18084,0.0083942]
["REGULATION OF T HELPER CELL DIFFERENTIATION",39,0.27476,0.11509,0.0084897]
["ASTROCYTE DIFFERENTIATION",85,0.19026,0.080356,0.0089546]
["POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY",31,0.30382,0.12881,0.0091749]
[]
["\nSupplementary Table 4 - List of top associated gene sets from Gene Ontology Biological Process. \nThe list is obtained upon application of a competitive test on gene-wise meta-analysis, as implemented in MAGMA (see Methods). \nFor each Term, the number of genes annotated to it, regression coefficient (BETA) and its standard error, p-value from the test is reported. \nAbbreviations: GO (Gene Ontology), BP (Biological Process), SE (standard error)\n"]